General Information of Drug (ID:
DR5306) |
Drug Name |
Antazoline
|
Synonyms |
Analergine; Antastan; Antasten; Antazolin; Antazolina; Antazolinum; Antihistal; Antistin; Antistine; Azalone; Histostab;Imidamin; Imidamine; Phenazolin; Phenazoline; Antazolina [Spanish]; Antazolinum [Latin]; Antazolina [INN-Spanish]; Antazoline (INN); Antazoline [INN:BAN]; Antazolinum [INN-Latin]; Ben-A-hist; N-Benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline; N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-N-(phenylmethyl)aniline; 2-(N-Benzylanilinomethyl)-2-imidazoline; 2-(N-Phenyl-N-benzylaminomethyl)imidazoline; 2-Phenyl-benzyl-amino-methylimidazolin; 2-Phenyl-benzyl-amino-methylimidazolin [German]; 4,5-Dihydro-N-phenyl-N-phenylmethyl-1H-imidazole-2-methanamine; 5512-M
|
Indication |
Nasal congestion
[ICD11: MD11]
|
Approved
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
265.35 |
Topological Polar Surface Area |
27.6 |
Heavy Atom Count |
20 |
Rotatable Bond Count |
5 |
Hydrogen Bond Donor Count |
1 |
Hydrogen Bond Acceptor Count |
2 |
Cross-matching ID |
- PubChem CID
- 2200
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D06FZX
- Formula
- C17H19N3
- Canonical SMILES
- C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3
- InChI
- InChI=1S/C17H19N3/c1-3-7-15(8-4-1)13-20(14-17-18-11-12-19-17)16-9-5-2-6-10-16/h1-10H,11-14H2,(H,18,19)
- InChIKey
- REYFJDPCWQRWAA-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.